4 completed. 2 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 2 |
Follow TAK-085: new trials by email Literature Review of TAK-085 trials Research Report on TAK-085
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood TAK-085, Not treated with omega-3-acid ethyl esters - Hyperlipidemia | Phase 4 | Completed | Takeda | 53 | 2016-12-27 | 2019-02-11 |
| Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation TAK-085 - Hyperlipidemia | Phase 4 | Completed | Takeda | 37 | 2016-08-04 | 2019-05-06 |
| Efficacy of TAK-085 in Participants With Hypertriglyceridemia Omega-3-acid ethyl esters 90 (TAK-085), Eicosapentaenoic acid-ethyl (EPA-E) - Hypertriglyceridemia | Phase 3 | Completed | Takeda | 611 | 2009-11-01 | 2016-09-20 |
| Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia omega-3-acid ethyl esters 90 (TAK-085), Eicosapentaenoic acid-ethyl (EPA) - Hypertriglyceridemia | Phase 3 | Completed | Takeda | 503 | 2009-11-01 | 2016-09-20 |
Hyperlipidemias (2) · Hypertriglyceridemia (2)
Takeda (4)
Japan (2)
Associate Professor, Clinical Cell Biology and Medicine (2)